Autres langues Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Produits pharmaceutiques

Marché Fermé - Sao Paulo 21:38:32 31/08/2026			Varia. 5j.	Varia. 1 janv.
79,75 ^BRL	-1,18%		-1,98%	+20,91%

31/08	Donald Trump prépare de nouveaux accords pour réduire le prix des médicaments
31/08	L'administration Trump s'apprête à annoncer des accords sur le prix des médicaments	RE

Autres langues

31/08	Trump announces new round of drug-pricing deals
31/08	Donald Trump prepares new agreements to reduce drug prices
31/08	Trump administration to announce drug pricing deals
31/08	Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
31/08	Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients
31/08	AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
28/08	AstraZeneca - Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
27/08	UK Shares Fall as Global Tensions Mount; AstraZeneca Drops
27/08	European Stocks Close Mostly Lower in Thursday Trading as Investors Await Fed Chair Speech
27/08	Global markets live: Apple, Meta, Nvidia, Salesforce, KKR…
27/08	AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients
27/08	AstraZeneca and Amgen announce positive Tezspire trial results in EoE
27/08	Astrazeneca-Medikament Tezspire erreicht Studienziel bei Ösophagitis
27/08	Amgen and AstraZeneca Demonstrate Positive Phase 3 Results For Tezspire In Eosinophilic Esophagitis
27/08	PPHE Hotel Group swings to half-year profit
27/08	AstraZeneca, Amgen's Tezspire Improves Eosinophilic Esophagitis Symptoms in Late-stage Trial
27/08	AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial
27/08	AstraZeneca's asthma drug Tezspire meets all goals in late-stage esophagitis trial
27/08	TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
27/08	UK Stocks-Factors to watch on August 27
21/08	FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case
18/08	TScan Therapeutics, Inc. And Amgen Inc. Terminate Research Collaboration And License Agreement
18/08	GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
18/08	CSL's Share Price Hits Six-Month High on Guidance Beat
17/08	Sandoz: diritti commerciali su alcuni biosimilari cinesi